Hemo Organic Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	1.64	-2.64	-0.55	-0.62	-0.48	Upgrade
Other Operating Activities	-1.38	30.68	19.13	-	-	Upgrade
Change in Accounts Receivable	-24.35	-0.02	-0.04	0.08	0.02	Upgrade
Change in Inventory	-14.16	0.15	0.02	-0.15	-0.01	Upgrade
Change in Accounts Payable	35.27	-30.92	-19.13	0.31	-0.19	Upgrade
Change in Other Net Operating Assets	-0.63	-9.17	1.64	0.34	0.53	Upgrade
Operating Cash Flow	-3.62	-11.9	1.07	-0.04	-0.14	Upgrade
Long-Term Debt Issued	2.42	12.03	0	-	-	Upgrade
Net Debt Issued (Repaid)	2.42	12.03	0	-	-	Upgrade
Financing Cash Flow	2.42	12.03	0	-	-	Upgrade
Net Cash Flow	-1.2	0.12	1.07	-0.04	-0.14	Upgrade
Free Cash Flow	-3.62	-11.9	1.07	-0.04	-0.14	Upgrade
Free Cash Flow Margin	-14.56%	-5267.26%	2231.25%	-64.85%	-170.58%	Upgrade
Free Cash Flow Per Share	-1.04	-3.44	0.31	-0.01	-0.04	Upgrade
Levered Free Cash Flow	-3.68	-10.94	1.28	0.19	-0.29	Upgrade
Unlevered Free Cash Flow	-3.68	-10.82	1.28	0.19	-0.29	Upgrade
Change in Net Working Capital	3.84	9.29	-1.62	-0.58	-0.01	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.